StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Incyte (INCY) PT Lowered to $83 at BofA/Merrill Lynch
April 24, 2018 9:17 AM
BofA/Merrill Lynch lowered its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Incyte (INCY) PT Lowered to $88 at JPMorgan
April 24, 2018 7:54 AM
Eli Lilly & Co. (LLY) & Incyte Corporation (INCY) Confirms FDA Advisory Committee Recommends Approval of Baricitinib 2mg and Against 4mg
April 24, 2018 6:01 AM
Incyte (INCY) PT Lowered to $75 at SunTrust Robinson Humphrey
April 24, 2018 1:06 AM
